These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex. el Mansari M; Blier P Br J Pharmacol; 1996 Jun; 118(3):681-9. PubMed ID: 8762094 [TBL] [Abstract][Full Text] [Related]
8. The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactin. de Rezende MG; Garcia-Leal C; Graeff FG; Del-Ben CM J Psychopharmacol; 2013 Dec; 27(12):1124-33. PubMed ID: 23325368 [TBL] [Abstract][Full Text] [Related]
9. Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine. Goldberg MR; Lowry RC; Musson DG; Birk KL; Fisher A; De Puy ME; Shadle CR J Clin Pharmacol; 1999 Feb; 39(2):192-9. PubMed ID: 11563413 [TBL] [Abstract][Full Text] [Related]
10. Sumatriptan does not stimulate PRL and GH secretion in acromegaly. Cuttica CM; Sessarego P; Valenti S; Falivene MR; Giusti M; Giordano G Minerva Endocrinol; 1995 Jun; 20(2):141-4. PubMed ID: 8531896 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine administration failed [corrected] to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment. Strachan AT; Leiper JB; Maughan RJ Exp Physiol; 2004 Nov; 89(6):657-64. PubMed ID: 15328306 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219 [TBL] [Abstract][Full Text] [Related]
15. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache. Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery. Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906 [TBL] [Abstract][Full Text] [Related]
17. Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects. Brunswick DJ; Goodman DB; O'Reardon JP; Chopra M; Amsterdam JD Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):477-80. PubMed ID: 15093954 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine. Rainero I; Valfrè W; Savi L; Gentile S; Pinessi L; Gianotti L; Arvat E; Ghigo E; Del Rizzo P; Calvelli P; Limone P J Endocrinol Invest; 2001 May; 24(5):310-4. PubMed ID: 11407649 [TBL] [Abstract][Full Text] [Related]
20. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]